RAFFA WEALTH MANAGEMENT, LLC’s Enanta Pharmaceuticals ENTA Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160	Hold	11	–	–	﹤0.01%	1294
2026 Q1	$139	Hold	11	–	–	﹤0.01%	1240
2025 Q4	$173	Hold	11	–	–	﹤0.01%	1138
2025 Q3	$132	Hold	11	–	–	﹤0.01%	1157
2025 Q2	$83	Hold	11	–	–	﹤0.01%	1091
2025 Q1	$61	Hold	11	–	–	﹤0.01%	1067
2024 Q4	$63	Hold	11	–	–	﹤0.01%	1103
2024 Q3	$114	Hold	11	–	–	﹤0.01%	1067
2024 Q2	$143	Hold	11	–	–	﹤0.01%	1129
2024 Q1	$192	Hold	11	–	–	﹤0.01%	1102
2023 Q4	$104	Hold	11	–	–	﹤0.01%	1046
2023 Q3	$123	Hold	11	–	–	﹤0.01%	1042
2023 Q2	$235	Hold	11	–	–	﹤0.01%	1029
2023 Q1	$445	Hold	11	–	–	﹤0.01%	985
2022 Q4	$512	Hold	11	–	–	﹤0.01%	944
2022 Q3	$571	Hold	11	–	–	﹤0.01%	994
2022 Q2	$520	Hold	11	–	–	﹤0.01%	1013
2022 Q1	$783	Hold	11	–	–	﹤0.01%	946
2021 Q4	$823	Hold	11	–	–	﹤0.01%	939
2021 Q3	$625	Hold	11	–	–	﹤0.01%	989
2021 Q2	$484	Hold	11	–	–	﹤0.01%	1049
2021 Q1	$543	Buy	+11	New	+$549	﹤0.01%	1036
2016 Q3	–	Sell	-17	Closed	-$375	–	876
2016 Q2	$375	Sell	17 -29	-63%	-$759	﹤0.01%	785
2016 Q1	$1.35K	Hold	46	–	–	﹤0.01%	325
2015 Q4	$1.52K	Hold	46	–	–	﹤0.01%	299
2015 Q3	$1.66K	Sell	46 -1	-2%	-$43	﹤0.01%	293
2015 Q2	$2.12K	Hold	47	–	–	﹤0.01%	267
2015 Q1	$1.44K	Buy	47 +30	+176%	+$1.17K	﹤0.01%	302
2014 Q4	$864	Hold	17	–	–	﹤0.01%	399
2014 Q3	$673	Hold	17	–	–	﹤0.01%	467
2014 Q2	$732	Hold	17	–	–	﹤0.01%	258
2014 Q1	$680	Hold	17	–	–	﹤0.01%	257
2013 Q4	$864	Buy	+17	New	+$412	﹤0.01%	399

Other funds holding ENTA

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's ENTA Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC held its Enanta Pharmaceuticals (ENTA) position steady in Q2 2026 at 11 shares worth $160. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in ENTA in Q4 2013 and has held it in 33 quarters since. The position peaked at $2.12K in Q2 2015. 17 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 11 shares of Enanta Pharmaceuticals worth $160 as of Q2 2026.
RAFFA WEALTH MANAGEMENT, LLC left its Enanta Pharmaceuticals share count unchanged in Q2 2026.
Enanta Pharmaceuticals made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1294 holding.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Enanta Pharmaceuticals in Q4 2013 and has held it in 33 quarters since.
RAFFA WEALTH MANAGEMENT, LLC's Enanta Pharmaceuticals position peaked at $2.12K in Q2 2015.
17 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.